H01*A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial. (26th September 2015) - Daniele, G.; Morabito, A.; Favaretto, A.; Filipazzi, V.; Rossi, A.; Gebbia, V.; Castiglione, F.; Cavanna, L.; Maiello, E.; Valmadre, G.; Costanzo, R.; Manzo, A.; et al.